Enzymatic and nonenzymatic in vitro hydrolysis of 2-methyl-2-[2-(methoxy)phenoxy]-4H-1,3-benzodioxin-4-one and 2-methoxyphenyl O-acetylsalicylate.
This paper is concerned with the synthesis and physical properties as well as the enzymatic and nonenzymatic in vitro hydrolysis of the potential aspirin prodrug MR 693 (5) and the salicylic acid prodrug guacetisalum (6). The half-lives of both prodrugs and the amount of aspirin regenerated in each hydrolytic run for 5 have been estimated over a wide range of pH values.
Department of Chemistry, University of Aarhus, Denmark.
M
M
Hundewadt
A
A
Senning
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism*; D001241:Aspirin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004146:Dioxanes / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D006868:Hydrolysis; D006899:Mixed Function Oxygenases / Q000378:metabolism
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004146:Dioxanes; D006899:Mixed Function Oxygenases; C043484:guaimesal; D001241:Aspirin; C023557:guacetisal